All posts by Jordan

2018 PCRC Investigator Development Pilot Funding Opportunity Announcement

We are pleased to announce that the Funding Opportunity Announcement (FOA) for the 2018 PCRC Investigator Development Pilot Program is now available: 

Interest Letters (required) are due June 1, 2018 @ 5pm Pacific and the full application is due July 16th, 2018 @ 5pm Pacific. Interest Letters and applications must be submitted electronically to Carey Candrian ([email protected]).


  • Eligible applicants are any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research is invited to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are strongly encouraged to apply. 
  • Eligible applicants are junior investigators meeting the NIH definition of “new investigator” (an investigator who has not yet competed successfully for a substantial NIH research grant). At least one of the Principal Investigators must be a PCRC member. To become a PCRC member, please complete an application online ( All pilot project applications should include a mentor with extramural funding.  

The Nursing and Related Clinical Sciences (NRCS) study section is changing!

The number of grant applications submitted to NIH and reviewed by the Nursing and Related Clinical Sciences (NRCS) study section has significantly increased beyond the capacity of a single study section.  Over the past few years, we have handled the large number of applications by reviewing some of the applications in an overflow standing special emphasis panel (ZRG1 NRCS-V 08).  We are happy to announce that we have established a second study section, and will begin running two separate study sections beginning with the June and July 2018 application deadlines.  NRCS will review applications focused on the clinical management of patients in varied institutional and specialty care settings including patients residing at home but receiving active treatment, and families served by certified hospice care. The new study section, Clinical Management of Patients in Community-based settings (CMPC) will review applications where the patients or their caregivers are engaged in self-management in the home or are cared for in primary/community care settings. Each study section will have its own membership roster with expertise for the specific study section represented.

Where will my application be reviewed? Applications are assigned to a study section based on the science proposed.

The (new) Nursing and Related Clinical Sciences (NRCS) study section will review applications addressing the clinical management of patients. Studies should have clear patient care implications or be closely associated with clinical practice. The focus of applications is on treatment that occurs in varied institutional and specialty care settings, including but not limited to hospital, nursing home, rehabilitation or long-term care facilities, ambulatory chemotherapy or infusion centers or ambulatory surgery centers, as well as patients living at home who are coping with symptoms associated with active treatment or hospice care. Examples of patient-care oriented disciplines that may be reviewed in the study section include, but are not limited to nursing, medicine, pharmacy, palliative care and rehabilitative therapies. Applications that use animal models or aim to explain the underlying pathophysiology of disease are excluded.

The Clinical Management of Patients in Community-based settings (CMPC) study section will review applications addressing the clinical management of patients in community, primary care and home-based settings.  Areas of emphasis include support for patient self-management of chronic conditions, improving quality of life for patients and caregivers of the chronically ill, survivorship care after treatment, and home care for patients with chronic or episodic illness. Applications may include disciplines such as nursing, medicine, social work, pharmacy, health psychology, and rehabilitative therapies. Applications that use animal models, large population-based datasets, or aim to explain the underlying pathophysiology of disease are excluded.

When will this start?  Applications submitted for the June and July 2018 receipt dates (to be reviewed in September and October) and thereafter will be assigned to either NRCS or CMPC. 

Now Accepting Applications: Training Institute for Dissemination and Implementation Research in Health (TIDIRH)

OBSSR in coordination with a number of NIH Institutes and Centers and the U.S. Department of Veterans Affairs, are hosting the Training Institute for Dissemination and Implementation Research in Health (TIDIRH) to provide participants with a thorough grounding in conducting dissemination and implementation (D&I) research in health across all areas of health and health care. In 2018, the institute will utilize a combination of a 4-month online course (six modules with related assignments) between August 13 and November 30 , 2018, and a 2-day in-person training to be held December 6-7, 2018, in Bethesda, MD. Faculty and guest lecturers will consist of leading experts in theory, implementation, and evaluation approaches to D&I; creating partnerships and multilevel, transdisciplinary research teams; research design, methods, and analyses appropriate for D&I; and conducting research at different and multiple levels of intervention (e.g., clinical, community, policy). Participants will be expected to return to their home institutions prepared to share what they have learned at the institute to help further the field of D&I research (e.g., giving talks, leading seminars, forming new collaborations, mentoring, submitting D&I grant proposals, etc.). Applications are due on June 12, 2018 12:00 p.m. ET. 

Apply Now

PCORI Funding Initiative: Symptom Management for Patients with Advanced Illness PFA for Cycle 2 2018.  

The Patient-Centered Outcomes Research Institute (PCORI) will be releasing the Symptom Management for Patients with Advanced Illness PFA for Cycle 2 2018.   

The goal of this funding initiative is to support patient- and caregiver-centered, comparative clinical effectiveness research to generate important findings that will aid decision making about symptom management in advanced illness. PCORI seeks to fund multiple high quality clinical studies that compare the effectiveness of evidence-based treatments for relief of common symptoms experienced by patients with serious, advanced illness. 

The mission of the PCORI is to improve the quality and relevance of evidence available to help patients, caregivers, clinicians, employers, insurers, and policy makers make informed health decisions. We invite you to review this funding announcement on our website and share this information with others who may be interested. 

The full funding announcement will be released on June 1, 2018. While this funding announcement was originally released in Cycle 2 2017, PCORI has made some changes to this version. We invite you to register for the Town Hall on June 19, 2018. 

If you have any questions, please contact [email protected].  

2018 Lasker Clinical Research Scholars Program

The National Institutes of Health, in partnership with the Lasker Foundation, is pleased to announce the 2018 Lasker Clinical Research Scholars Program. This is an opportunity for 8 to 10 years of funding for clinical researchers. This unique program provides Scholars with 5 to 7 years of support as an independent principal investigator in the NIH Intramural Research Program, followed by three years of continued financial support, either at the NIH or at an outside medical center/research institution.

Candidates must have a clinical doctoral degree (MD, MD/PhD, DO, DDS, DMD, RN/PhD or equivalent) and a professional license to practice in the United States. The program is intended for investigators at the early stages of their independent careers, and at the time of application, candidates must be no more than 10 years from completion of their core residency training. Candidates generally will have completed or will be completing a post-residency clinical fellowship and will have demonstrated significant patient-oriented research experience to qualify for a tenure-track level appointment.

Application deadline: August 31, 2018

For more information, please reference the documents attached here, or visit:

Training in Interprofessional Education for Palliative Care in Oncology

The University of Louisville School of Medicine’s Interdisciplinary Program for Palliative Care and Chronic Illness has received funding for Training in Interprofessional Education for Palliative Care in Oncology from the National Cancer Institute to assist in developing interprofessional education curricula.  A national training program, iPEX (InterProfessional Education eXchange), is being launched to train, support and provide resources to selected faculty teams.

We invite you to join a national training program in Interprofessional Education for Supportive Care in Oncology. This project, funded by the National Cancer Institute (R25CA203637), has research components and IRB approval.

Only 10 interprofessional teams of 3-5 health science faculty will be selected in 2018. Application is now open and will be extended until April 30, 2018 or until enrollment limits are reached.

For more information about iPEX, the InterProfessional Education eXchange: A National Program to Advance Interprofessional Education in Cancer Care, visit:

Pragmatic Trials for Dementia Care in Long-term Services and Support Settings R61/R33

Funding Opportunity Number: PAR-18-585
CFDA Number: 93.866

National Institute on Aging (NIA) invites applications for pragmatic trials for dementia care in Long-term Services and Support (LTSS) settings which will: (1) be designed to address practical comparative questions faced by Alzheimer’s disease (AD) and AD-related dementia (ADRD) patients, clinicians and caregivers (both paid and unpaid); (2) include broad and diverse populations; and (3) be conducted in real-world settings. These trials are intended to produce results that can be directly adopted by healthcare providers, patients or caregivers for rapid translation.

Deadline Dates: Applications may be submitted on or after February 23, 2018. The deadline for receipt of optional letters of intent is 30 days prior to the application due date. The deadlines for receipt of full applications are: March 27, 2018; February 20, 2019; and February 20, 2020, by 5:00 PM local time of applicant organization. This FOA will expire on February 21, 2020.

For more details, visit:

EOL and PC Health Literacy R01/R21: Improving Outcomes in Serious, Advanced Illness

Types of studies may include innovative methods or approaches such as qualitative, mixed methods, observational, quasi-experimental, and experimental with focus on individual- and family-centered outcomes. It is strongly encouraged that the investigative teams be interdisciplinary and include nurse scientists and early stage investigators. Investigators are also encouraged to consider using existing palliative care research networks, such as the Palliative Care Research Cooperative Group, to carry out small, multi-site trials when appropriate.

For more information, visit: